Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
17.2M
-
Number of holders
-
31
-
Total 13F shares, excl. options
-
1.82M
-
Shares change
-
+476K
-
Total reported value, excl. options
-
$6.68M
-
Value change
-
+$1.25M
-
Number of buys
-
20
-
Number of sells
-
-16
-
Price
-
$3.68
Significant Holders of Journey Medical Corp - Common Stock (DERM) as of Q1 2024
42 filings reported holding DERM - Journey Medical Corp - Common Stock as of Q1 2024.
Journey Medical Corp - Common Stock (DERM) has 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.82M shares
of 17.2M outstanding shares and own 10.56% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (310K shares), RENAISSANCE TECHNOLOGIES LLC (271K shares), ACADIAN ASSET MANAGEMENT LLC (223K shares), AMERICAN FINANCIAL GROUP INC (180K shares), TANG CAPITAL MANAGEMENT LLC (139K shares), Walleye Capital LLC (134K shares), GEODE CAPITAL MANAGEMENT, LLC (89.1K shares), NEUBERGER BERMAN GROUP LLC (81.4K shares), BlackRock Inc. (49.4K shares), and XTX Topco Ltd (36.5K shares).
This table shows the top 31 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.